Figure 4.
Radiographic response of Central nervous system (CNS) hemangioblastoma treated with belzutifan. (A) Axial T1 post-contrast MRI demonstrating a left peri-pontine enhancing lesion consistent with a hemangioblastoma on baseline imaging. (B) A notable decrease in size is observed 40 days after initiating belzutifan. (C) There is a further slight decrease in size observed 7 months after initiating belzutifan.

Radiographic response of Central nervous system (CNS) hemangioblastoma treated with belzutifan. (A) Axial T1 post-contrast MRI demonstrating a left peri-pontine enhancing lesion consistent with a hemangioblastoma on baseline imaging. (B) A notable decrease in size is observed 40 days after initiating belzutifan. (C) There is a further slight decrease in size observed 7 months after initiating belzutifan.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close